118 related articles for article (PubMed ID: 11073856)
1. P-Selectin-dependent inhibition of thrombosis during venous stasis.
Eppihimer MJ; Schaub RG
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2483-8. PubMed ID: 11073856
[TBL] [Abstract][Full Text] [Related]
2. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.
Wakefield TW; Strieter RM; Schaub R; Myers DD; Prince MR; Wrobleski SK; Londy FJ; Kadell AM; Brown SL; Henke PK; Greenfield LJ
J Vasc Surg; 2000 Feb; 31(2):309-24. PubMed ID: 10664500
[TBL] [Abstract][Full Text] [Related]
3. Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules.
Eppihimer MJ; Schaub RG
Microcirculation; 2001 Feb; 8(1):15-24. PubMed ID: 11296849
[TBL] [Abstract][Full Text] [Related]
4. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.
Myers DD; Henke PK; Wrobleski SK; Hawley AE; Farris DM; Chapman AM; Knipp BS; Thanaporn P; Schaub RG; Greenfield LJ; Wakefield TW
J Vasc Surg; 2002 Nov; 36(5):928-38. PubMed ID: 12422103
[TBL] [Abstract][Full Text] [Related]
5. P-selectin and leukocyte microparticles are associated with venous thrombogenesis.
Myers DD; Hawley AE; Farris DM; Wrobleski SK; Thanaporn P; Schaub RG; Wagner DD; Kumar A; Wakefield TW
J Vasc Surg; 2003 Nov; 38(5):1075-89. PubMed ID: 14603220
[TBL] [Abstract][Full Text] [Related]
6. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model.
Amersi F; Dulkanchainun T; Nelson SK; Farmer DG; Kato H; Zaky J; Melinek J; Shaw GD; Kupiec-Weglinski JW; Horwitz LD; Horwitz MA; Busuttil RW
Transplantation; 2001 Jan; 71(1):112-8. PubMed ID: 11211175
[TBL] [Abstract][Full Text] [Related]
7. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.
Wang K; Zhou Z; Zhou X; Tarakji K; Topol EJ; Lincoff AM
J Am Coll Cardiol; 2001 Aug; 38(2):577-82. PubMed ID: 11499755
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection.
Opal SM; Sypek JP; Keith JC; Schaub RG; Palardy JE; Parejo NA
Shock; 2001 Apr; 15(4):285-90. PubMed ID: 11303727
[TBL] [Abstract][Full Text] [Related]
9. P-selectin antagonism causes dose-dependent venous thrombosis inhibition.
Myers DD; Schaub R; Wrobleski SK; Londy FJ; Fex BA; Chapman AM; Greenfield LJ; Wakefield TW
Thromb Haemost; 2001 Mar; 85(3):423-9. PubMed ID: 11307808
[TBL] [Abstract][Full Text] [Related]
10. rPSGL-1-Ig, a recombinant PSGL-1-Ig fusion protein, ameliorates LPS-induced acute lung injury in mice by inhibiting neutrophil migration.
Shao HZ; Qin BY
Cell Mol Biol (Noisy-le-grand); 2015 Feb; 61(1):1-6. PubMed ID: 25817339
[TBL] [Abstract][Full Text] [Related]
11. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.
Kumar A; Villani MP; Patel UK; Keith JC; Schaub RG
Circulation; 1999 Mar; 99(10):1363-9. PubMed ID: 10077522
[TBL] [Abstract][Full Text] [Related]
12. Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion.
Wang K; Zhou X; Zhou Z; Tarakji K; Qin JX; Sitges M; Shiota T; Forudi F; Schaub RG; Kumar A; Penn MS; Topol EJ; Lincoff AM
Thromb Haemost; 2002 Jul; 88(1):149-54. PubMed ID: 12152656
[TBL] [Abstract][Full Text] [Related]
13. Endothelial selectin blockade attenuates lung permeability of experimental acid aspiration.
Kyriakides C; Austen W; Wang Y; Favuzza J; Moore FD; Hechtman HB
Surgery; 2000 Aug; 128(2):327-31. PubMed ID: 10923012
[TBL] [Abstract][Full Text] [Related]
14. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.
Thanaporn P; Myers DD; Wrobleski SK; Hawley AE; Farris DM; Wakefield TW; Henke PK
Surgery; 2003 Aug; 134(2):365-71. PubMed ID: 12947342
[TBL] [Abstract][Full Text] [Related]
15. Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine.
Bienvenu JG; Tanguay JF; Théorêt JF; Kumar A; Schaub RG; Merhi Y
Circulation; 2001 Feb; 103(8):1128-34. PubMed ID: 11222477
[TBL] [Abstract][Full Text] [Related]
16. P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces.
Théorêt JF; Bienvenu JG; Kumar A; Merhi Y
J Pharmacol Exp Ther; 2001 Aug; 298(2):658-64. PubMed ID: 11454928
[TBL] [Abstract][Full Text] [Related]
17. Decreased venous thrombosis with an oral inhibitor of P selectin.
Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
[TBL] [Abstract][Full Text] [Related]
18. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1.
Tanguay JF; Geoffroy P; Sirois MG; Libersan D; Kumar A; Schaub RG; Merhi Y
Thromb Haemost; 2004 Jun; 91(6):1186-93. PubMed ID: 15175806
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte mediated vein injury and thrombosis is reduced by a lipoxygenase inhibitor.
Schaub RG; Yamashita A
Exp Mol Pathol; 1986 Dec; 45(3):343-53. PubMed ID: 3025012
[TBL] [Abstract][Full Text] [Related]
20. A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis.
Quarmby J; Smith A; Collins M; Cederholm-Williams S; Burnand K
J Vasc Surg; 1999 Jul; 30(1):139-47. PubMed ID: 10394164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
